Amsterdam, NL / Oakland, CA, USA — AkzoNobel, a global leader in paints and coatings, and Albert Invent, who is building the future of chemistry R&D, today announced an AI transformation partnership with AkzoNobel’s global R&D organization. AkzoNobel’s Digital Workbench initiative is designed to connect laboratory workflows, structure scientific data, and put modern AI tools […]
New capabilities unify Certara’s biosimulation software, products, datasets, and scientific expertise with AI-driven agents to deliver specialized insights for life sciences RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, is partnering with NVIDIA to advance Certara’s open integrated AI platform, unifying its scientific software, regulatory expertise, and proprietary datasets […]
Burlingame, CA – Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault. Lilly TuneLab was created by Lilly to accelerate biotech innovation by enabling participating companies […]
Molecular Universe Introduces MU-StarSeeker, an Agent-Managed AI Platform as Part of its Latest Frontier Workflow Automation MU-3.0 Release MU-StarSeeker in MU-3.0 release expands Molecular Universe from AI-assisted research workflow to agent-managed materials discovery automation, from molecule search and formulation optimization to cell performance prediction and manufacturing quality guidance MU-3.0 coverage expands to Sodium-ion (Na-ion) given […]
Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific and AI strategy across in silico predictive modeling, translational safety analytics, and data-driven drug development solutions. BOSTON, USA – Instem, a leading provider of SaaS solutions […]
New user interface provides visual insights to guide compound optimisation CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform. The new interface facilitates chemists’ access to accurate affinity predictions that guide the design of potent compounds, and reduces the synthesis and testing burden in lead optimisation. Originally developed as a command-line tool for expert computational users, QuanSA (Quantitative Surface-Field […]
New user interface provides visual insights to guide compound optimisation CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA™ plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform. […]
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the extension of two separate research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). The extended projects support ongoing federal […]
Newly created role underscores commitment to customer-driven research and scientific excellence CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced the appointment of Dr Nathan Brown as Director of Science, strengthening the company’s position in delivering scientifically rigorous software that addresses real-world efficiency and productivity challenges in molecular discovery. Nathan […]
New AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
